Featured news in The Life Sciences Report
|
|
|
MiMedx Group Inc. (MDXG:NASDAQ)
MDXG INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving MiMedx Group Inc. and a Lead Plaintiff Deadline of April 25, 2018 (4/18/2018)
|
|
view 
|
|
|
|
|
|
Cesca Therapeutics Inc. (KOOL:NASDAQ)
Blog Exposure - AcelRx Pharma Completes the Human Factors Study for DSUVIA (4/18/2018)
|
|
view
|
|
|
|
|
|
ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Today's Free Reports ProMIS Neurosciences, Spectral Medical, GeneNews, and Sernova (4/18/2018)
|
|
view
|
|
|
|
|
|
Celgene Corp. (CELG:NASDAQ)
Agios' Leukemia Drug Bodes Well for Growth & Strong Pipeline (4/18/2018)
|
|
view
|
|
|
|
|
|
MiMedx Group Inc. (MDXG:NASDAQ)
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In MiMedx Group, Inc. (Nasdaq: MDXG) To Contact The Firm (4/18/2018)
|
|
view
|
|
|
|
MiMedx Group Inc. (MDXG:NASDAQ)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 - MDXG (4/17/2018)
|
|
view
|
|
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Mesoblast Clinical Program Update for MPC-150-IM in Patients With Chronic Heart Failure (4/18/2018)
|
|
view
|
|
|
|
|
|
Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series(TM) Products That Provide Automated, Closed System Cellular Processing (4/17/2018)
|
|
view
|
|
|
|
|
|
Celgene Corp. (CELG:NASDAQ)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Celgene Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 - CELG (4/16/2018)
|
|
view
|
